MAY 2018 - ADAPTING EUROPEAN POLICIES
The Confederation of Meningitis Organisations (CoMO), the Coalition for Life-Course Immunisation (CLCI), along with other key stakeholders, have co-authored and contributed to a document that was initiated and funded by MSD and produced by the Health Policy Partnership. The report discusses what a life-course approach to vaccination could look like and how it could be implemented into future vaccination policies.
The report highlights that adopting a life-course approach to vaccination could positively impact individuals, the wider community, and socioeconomic factors. For example:
The individual: taking a life-course approach to vaccination may help boost the individuals’ immunity over their lifetime, which may make them more resistant to other diseases
Public Health: vaccinating individuals helps to stop the spread of infectious disease to vulnerable, unvaccinated populations.
Socioeconomic impact: through preventing illness, vaccinating individuals at all ages can reduce hospitalisation rates and increase productivity in the workplace.
Research suggests that shifting to a life-course approach to vaccination will require policymakers to make several changes.
These changes fall into 5 categories:
Involving global, EU and public health leaders
Changing the public’s perception of vaccination
Engaging healthcare professionals
Integrating vaccination into non-healthcare settings, such as schools or workplaces
Improving vaccine surveillance, data and research.
Read the full report to find out more.
Some of the co-authors of the report have also penned an open letter to key members of DG-Santé. In the letter, they call on all stakeholders to adopt a life-course approach to vaccination. Read the open letter here.
If you have any questions about Life Course Immunisation or any aspects of the report please get in touch.
Founded in 2017, the Coalition for Life-course Immunisation (CLCI) is a network of European experts from a diverse range of sectors. CLCI advocates that if vaccine-preventable diseases are to be eradicated across Europe, a life-course approach to vaccination is one of the tools that should be adopted.